A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts

Εμφάνιση άλλων εκδόσεων (1)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	van Leeuwen, N, Nijpels, G, Becker, M, Deshmukh, H, Zhou, K, Stricker, B, Uitterlinden, A, Hofman, A, van 't Riet, E, Palmer, C, Guigas, B, Slagboom, P, Durrington, P, Calle, R, Neil, A, Hitman, G, Livingstone, S, Colhoun, H, Holman, R, McCarthy, M, Dekker, J, 't Hart, L, Pearson, E
Μορφή:	Journal article
Έκδοση:	2012

Παρόμοια τεκμήρια

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts.
ανά: van Leeuwen, N, κ.ά.
Έκδοση: (2012)

A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of two Dutch and two UK cohorts
ανά: 't Hart, L, κ.ά.
Έκδοση: (2011)

The role of ATM in response to metformin treatment and activation of AMPK.
ανά: Zhou, K, κ.ά.
Έκδοση: (2012)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Colhoun, H, κ.ά.
Έκδοση: (2005)

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke
ανά: Newman, C, κ.ά.
Έκδοση: (2005)

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
ανά: Thomason, M, κ.ά.
Έκδοση: (2004)

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Hitman, G, κ.ά.
Έκδοση: (2007)

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS)
ανά: DeMicco, D, κ.ά.
Έκδοση: (2005)

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Neil, H, κ.ά.
Έκδοση: (2006)

Effect of atorvastatin on stroke in patients with type 2 diabetes: factors predicting the risk of stroke in the Collaborative Atorvastatin Diabetes Study (CARDS)
ανά: Hitman, G, κ.ά.
Έκδοση: (2005)

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Colhoun, H, κ.ά.
Έκδοση: (2009)

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
ανά: Colhoun, H, κ.ά.
Έκδοση: (2011)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Raikou, M, κ.ά.
Έκδοση: (2007)

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
ανά: Colhoun, H, κ.ά.
Έκδοση: (2004)

Change in Lp-PLA2 With Risk Change on Statin Therapy in the Collaborative Atorvastatin Diabetes Study (CARDS)
ανά: Betteridge, D, κ.ά.
Έκδοση: (2009)

Role of Mitochondria in the Mechanism(s) of Action of Metformin
ανά: Guillaume Vial, κ.ά.
Έκδοση: (2019-05-01)

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.
ανά: Zhou, K, κ.ά.
Έκδοση: (2014)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
ανά: Zhou, K, κ.ά.
Έκδοση: (2011)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
ανά: Zhou, K, κ.ά.
Έκδοση: (2011)

Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)
ανά: Charlton-Menys, V, κ.ά.
Έκδοση: (2009)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
ανά: Colhoun, H, κ.ά.
Έκδοση: (2002)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Charlton-Menys, V, κ.ά.
Έκδοση: (2009)

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Charlton-Menys, V, κ.ά.
Έκδοση: (2009)

Heritability of variation in glycaemic response to metformin: A genome-wide complex trait analysis
ανά: Zhou, K, κ.ά.
Έκδοση: (2014)

Cost-effectiveness of atorvastatin (10mg) in patients with type 2 diabetes without coronary heart disease: CARDS trial analysis and extrapolation
ανά: Raikou, M, κ.ά.
Έκδοση: (2005)

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
ανά: Newman, C, κ.ά.
Έκδοση: (2008)

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
ανά: Newman, C, κ.ά.
Έκδοση: (2006)

C-reactive Protein and Amyloid A as Predictors of Cardiovascular Events in Type 2 Diabetes in CARDS
ανά: Charlton-Menys, V, κ.ά.
Έκδοση: (2009)

Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.
ανά: Mahvash Zakikhani, κ.ά.
Έκδοση: (2012-01-01)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.
ανά: Soedamah-Muthu, S, κ.ά.
Έκδοση: (2003)

Metformin and mortality. Reply to Lund SS [letter]
ανά: Stevens, R, κ.ά.
Έκδοση: (2013)

Metformin and mortality. Reply to Lund SS [letter].
ανά: Stevens, R, κ.ά.
Έκδοση: (2013)

The effect of atorvastatin therapy on tumour necrosis factor-α and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease
ανά: Soedamah-Muthu, S, κ.ά.
Έκδοση: (2011)

Metformin and risk of cardiovascular disease.
ανά: Turner, R, κ.ά.
Έκδοση: (1999)

Risk of anaemia with long-term metformin use in a community setting
ανά: Donnelly, L, κ.ά.
Έκδοση: (2017)

The sustained influence of metformin therapy on circulating GLP-1 levels in individuals with and without type 2 diabetes
ανά: Preiss, D, κ.ά.
Έκδοση: (2016)

ANALISIS TERHADAP PERLINDUNGAN HUKUM BAGI NASABAH PENGGUNA ATM (SKIMMING KARTU ATM PADA MESIN ATM BANK X)
ανά: , Ronald Arthur Saiya, κ.ά.
Έκδοση: (2014)

Identifying the Latitude and Longitude of ATMs in ATM Networks
ανά: Niloofar Haghjoo, κ.ά.
Έκδοση: (2024-06-01)

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
ανά: Elisabet Cuyàs, κ.ά.
Έκδοση: (2019-03-01)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
ανά: Holman, R, κ.ά.
Έκδοση: (1989)